8-KCorporate ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Bylaw Amendment (Feb 2, 2007)

Filed February 2, 2007For Securities:CVS

Summary

CVS Health Corp. (CVS) filed a Current Report (8-K) on February 2, 2007, primarily to disclose amendments to its corporate by-laws, effective February 2, 2007. These changes are significant for corporate governance and investor rights. The amendments transition the voting standard for director elections in uncontested situations from a plurality to a majority vote, meaning a nominee must receive more 'for' votes than 'against' votes to be elected. This move aligns with a growing trend towards greater shareholder say in board composition. Additionally, the by-laws now incorporate new Delaware law provisions requiring incumbent directors to provide advance, irrevocable resignations prior to being nominated for re-election. This strengthens accountability and provides a clearer path for board refreshment. The filing also includes amendments to establish procedures and notice requirements for shareholder nominations of directors and the consideration of shareholder proposals, further enhancing shareholder engagement and transparency. These changes are separate from, but do not modify, further by-law amendments planned in connection with the pending merger with Caremark Rx, Inc.

Key Highlights

  • 1CVS Corporation amended its by-laws, effective February 2, 2007.
  • 2Adoption of a majority voting standard for director elections in uncontested situations.
  • 3Nominees now require more 'for' votes than 'against' votes to be elected in uncontested elections.
  • 4Implementation of new requirements for advance, irrevocable director resignations, aligning with Delaware law.
  • 5Establishment of procedures and notice requirements for shareholder nominations of directors.
  • 6Formalization of procedures for considering shareholder proposals at meetings.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and detail amendments to CVS Corporation's by-laws, which became effective on February 2, 2007. These amendments focus on corporate governance, specifically related to the election of directors and shareholder engagement.

In uncontested elections, the voting standard for electing directors has changed from a plurality to a majority vote. This means a nominee must receive more votes cast in favor of their election than votes cast against their election to be successful. A plurality vote will still apply if the number of nominees exceeds the number of directors to be elected.

The amended by-laws now require incumbent directors to submit an irrevocable resignation to the Board prior to being nominated for re-election. This change reflects new Delaware law and aims to enhance board accountability.

While these by-law amendments are effective independently, the filing notes that additional by-law amendments are planned to be effected in connection with, and conditioned upon, the consummation of the merger transaction with Caremark Rx, Inc. These current amendments do not modify or affect those future changes.